Related Experiment Video
Updated: Feb 23, 2026

14:52
Computerized Dynamic Posturography for Postural Control Assessment in Patients with Intermittent Claudication
Published on: December 11, 2013
12.1K
Test-retest reliability of static postural control in people with multiple sclerosis
Maria Mercedes Reguera-García1, Fernanda de Souza-Teixeira2, Jose Antonio de Paz Fernández3
1School of Health Science, SALBIS Research Group, University of León, Spain.
Journal of Physical Therapy Science
|September 8, 2017
Summary
Stabilometric measurements of the Centre of Pressure (CoP) show good to excellent reliability for individuals with Multiple Sclerosis (MS). Speed and Side Length are recommended for monitoring postural control in MS patients.
Area of Science:
- Neurology
- Biomedical Engineering
- Rehabilitation Science
Background:
- Multiple Sclerosis (MS) is a chronic neurological disease affecting balance and mobility.
- Postural control assessment is crucial for managing MS progression.
- Stabilometry provides objective measures of postural control.
Purpose of the Study:
- To evaluate the intraday test-retest reliability of stabilometric measurements of the Centre of Pressure (CoP).
- To determine the consistency of CoP measurements in individuals with Multiple Sclerosis (MS) under various conditions.
Main Methods:
- 18 participants with MS underwent stabilometric testing on a force platform.
- Measurements were taken with eyes open/closed on rigid and foam surfaces.
- Intraclass correlation coefficient (ICC) and coefficient of variation (CV) assessed reliability.
Main Results:
- High reliability (ICC=0.69-0.92) was observed for CoP measurements across all conditions.
- X Speed, Y Speed, and Side Length demonstrated the highest consistency.
- Intraday test-retest reliability was good to excellent.
Conclusions:
- Stabilometric measures, particularly X Speed, Y Speed, and Side Length, are reliable for assessing postural control in MS.
- These variables can be effectively used for monitoring disease progression and treatment efficacy in MS patients.

